|
|
Rwanda FDA-HMP-MA-1921
|
SERETIDE 100/50MCG DISKUS
|
FLUTICASONE PROPRIONATE MICRONIZED/SALMETEROL XINAFOATE MICRONIZED
|
Glaxo wellcome Production
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-2083
|
SERETIDE 50/250MCG DISKUS
|
SALMETEROL XINAFOATE MICRONIZED /FLUTICASONE PROPRIONATE MICRONIZED
|
Glaxo Wellcome Production
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1920
|
SERETIDE 500mcg/50mcg Diskus
|
Fluticasone propionate and salmeterol
|
Glaxo wellcome Production
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-0642
|
FLIXONASE AQUEOUS NASAL SPRAY
|
Fluticasone Propionate (micronized), 0.05 %
|
GLAXO WELLCOME S.A.,
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-2202
|
TICANASE NASAL SPRAY
|
Fluticasone Propionate
|
EUROPEAN EGYPTIAN PHARMACEUTICAL INDUSTRIES
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-2207
|
TICANASE PLUS
|
Azelastine Hydrochloride: 137 mcg / dose (0.137 ml) Fluticasone propionate 50 mcg / dose (0.137 ml)
|
EUROPEAN EGYPTIAN PHARMACEUTICAL INDUSTRIES
|
Registered
|
Details →
|